Literature DB >> 26875936

(99m)Tc-bioorthogonal click chemistry reagent for in vivo pretargeted imaging.

María Fernanda García1, Xiuli Zhang2, Manankumar Shah3, Jessica Newton-Northup4, Pablo Cabral5, Hugo Cerecetto6, Thomas Quinn7.   

Abstract

Metal-free click chemistry has become an important tool for pretargeted approaches in the molecular imaging field. The application of bioorthogonal click chemistry between a pretargeted trans-cyclooctene (TCO) derivatized monoclonal antibody (mAb) and a (99m)Tc-modified 1,2,4,5-tetrazine for tumor imaging was examined in vitro and in vivo. The HYNIC tetrazine compound was synthesized and structurally characterized, confirming its identity. Radiolabeling studies demonstrated that the HYNIC tetrazine was labeled with (99m)Tc at an efficiency of >95% and was radiochemically stable. (99m)Tc-HYNIC tetrazine reacted with the TCO-CC49 mAb in vitro demonstrating its selective reactivity. In vivo biodistribution studies revealed non-specific liver and GI uptake due to the hydrophobic property of the compound, however pretargeted SPECT imaging studies demonstrated tumor visualization confirming the success of the cycloaddition reaction in vivo. These results demonstrated the potential of (99m)Tc-HYNIC-tetrazine for tumor imaging with pretargeted mAbs.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  (99m)Tc–HYNIC; Click chemistry; Monoclonal antibody; Pretargeted imaging

Mesh:

Substances:

Year:  2016        PMID: 26875936      PMCID: PMC4841469          DOI: 10.1016/j.bmc.2016.01.046

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  40 in total

Review 1.  The role of coordination chemistry in the development of target-specific radiopharmaceuticals.

Authors:  Shuang Liu
Journal:  Chem Soc Rev       Date:  2004-08-16       Impact factor: 54.564

2.  In vivo chemistry for pretargeted tumor imaging in live mice.

Authors:  Raffaella Rossin; Pascal Renart Verkerk; Sandra M van den Bosch; Roland C M Vulders; Iris Verel; Johan Lub; Marc S Robillard
Journal:  Angew Chem Int Ed Engl       Date:  2010-04-26       Impact factor: 15.336

3.  Molecular imaging in cancer.

Authors:  Ralph Weissleder
Journal:  Science       Date:  2006-05-26       Impact factor: 47.728

Review 4.  Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides.

Authors:  Shuang Liu
Journal:  Adv Drug Deliv Rev       Date:  2008-04-23       Impact factor: 15.470

Review 5.  Pretargeted radioimmunotherapy of cancer: progress step by step.

Authors:  Otto C Boerman; Frank G van Schaijk; Wim J G Oyen; Frans H M Corstens
Journal:  J Nucl Med       Date:  2003-03       Impact factor: 10.057

6.  Use of specific antibody for rapid clearance of circulating blood background from radiolabeled tumor imaging proteins.

Authors:  D Goodwin; C Meares; C Diamanti; M McCall; C Lai; F Torti; M McTigue; B Martin
Journal:  Eur J Nucl Med       Date:  1984

Review 7.  Targeted therapy of cancer with radiolabeled antibodies.

Authors:  David M Goldenberg
Journal:  J Nucl Med       Date:  2002-05       Impact factor: 10.057

8.  Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics.

Authors:  Brian M Zeglis; Christian Brand; Dalya Abdel-Atti; Kathryn E Carnazza; Brendon E Cook; Sean Carlin; Thomas Reiner; Jason S Lewis
Journal:  Mol Pharm       Date:  2015-08-31       Impact factor: 4.939

9.  Tetrazine-based cycloadditions: application to pretargeted live cell imaging.

Authors:  Neal K Devaraj; Ralph Weissleder; Scott A Hilderbrand
Journal:  Bioconjug Chem       Date:  2008-12       Impact factor: 4.774

Review 10.  Molecular targeted α-particle therapy for oncologic applications.

Authors:  Thaddeus J Wadas; Darpan N Pandya; Kiran Kumar Solingapuram Sai; Akiva Mintz
Journal:  AJR Am J Roentgenol       Date:  2014-08       Impact factor: 3.959

View more
  12 in total

1.  Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry.

Authors:  Holly A Bilton; Zainab Ahmad; Nancy Janzen; Shannon Czorny; John F Valliant
Journal:  J Vis Exp       Date:  2017-02-04       Impact factor: 1.355

Review 2.  Click Chemistry and Radiochemistry: The First 10 Years.

Authors:  Jan-Philip Meyer; Pierre Adumeau; Jason S Lewis; Brian M Zeglis
Journal:  Bioconjug Chem       Date:  2016-11-22       Impact factor: 4.774

3.  Noninvasive Evaluation of EGFR Expression of Digestive Tumors Using 99mTc-MAG3-Cet-F(ab')2-Based SPECT/CT Imaging.

Authors:  Dai Shi; Yiqiu Zhang; Zhan Xu; Zhan Si; Yuan Cheng; Dengfeng Cheng; Guobing Liu
Journal:  Mol Imaging       Date:  2022-06-24       Impact factor: 3.250

4.  A Pretargeted Imaging Strategy for EGFR-Positive Colorectal Carcinoma via Modulation of Tz-Radioligand Pharmacokinetics.

Authors:  Lin Qiu; Qingyu Lin; Zhan Si; Hui Tan; Guobing Liu; Jun Zhou; Tingting Wang; Yue Chen; Yingzhao Huang; Tao Yu; Mingzhi Jin; Dengfeng Cheng; Hongcheng Shi
Journal:  Mol Imaging Biol       Date:  2020-09-10       Impact factor: 3.488

5.  CD11b-Based Pre-Targeted SPECT/CT Imaging Allows for the Detection of Inflammation in Aortic Aneurysm.

Authors:  Xiaonan Zhou; Kai Zhu; Yiqiu Zhang; Yang Ming; Dai Shi; Hui Tan; Bitao Xiang; Shichao Zhu; Dengfeng Cheng; Hao Lai; Chunsheng Wang; Guobing Liu
Journal:  J Inflamm Res       Date:  2022-03-16

6.  Site-specific conjugation allows modulation of click reaction stoichiometry for pretargeted SPECT imaging.

Authors:  Danielle Mandikian; Hanine Rafidi; Pragya Adhikari; Priya Venkatraman; Lidia Nazarova; Gabriel Fung; Isabel Figueroa; Gregory Z Ferl; Sheila Ulufatu; Jason Ho; Cynthia McCaughey; Jeffrey Lau; Shang-Fan Yu; Saileta Prabhu; Jack Sadowsky; C Andrew Boswell
Journal:  MAbs       Date:  2018-10-04       Impact factor: 5.857

Review 7.  Pretargeted Nuclear Imaging and Radioimmunotherapy Based on the Inverse Electron-Demand Diels-Alder Reaction and Key Factors in the Pretargeted Synthetic Design.

Authors:  Lin Qiu; Wujian Mao; Hongyan Yin; Hui Tan; Dengfeng Cheng; Hongcheng Shi
Journal:  Contrast Media Mol Imaging       Date:  2019-08-25       Impact factor: 3.161

8.  A 99mTc-Labelled Tetrazine for Bioorthogonal Chemistry. Synthesis and Biodistribution Studies with Small Molecule trans-Cyclooctene Derivatives.

Authors:  Alyssa Vito; Hussain Alarabi; Shannon Czorny; Omid Beiraghi; Jeff Kent; Nancy Janzen; Afaf R Genady; Salma A Al-Karmi; Stephanie Rathmann; Zoya Naperstkow; Megan Blacker; Lisset Llano; Paul J Berti; John F Valliant
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

9.  Pretargeting of internalizing trastuzumab and cetuximab with a 18F-tetrazine tracer in xenograft models.

Authors:  Outi Keinänen; Kimberly Fung; Jacob Pourat; Vilma Jallinoja; Delphine Vivier; NagaVara Kishore Pillarsetty; Anu J Airaksinen; Jason S Lewis; Brian M Zeglis; Mirkka Sarparanta
Journal:  EJNMMI Res       Date:  2017-12-02       Impact factor: 3.138

Review 10.  New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology.

Authors:  Anna Lucia Tornesello; Luigi Buonaguro; Maria Lina Tornesello; Franco Maria Buonaguro
Journal:  Molecules       Date:  2017-08-02       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.